Source: San Francisco Business Times
Posted: April 26, 2006
Geron Corp. said Wednesday that it was granted a patent covering the production of insulin secreting cells from human embryonic stem cells.
Commentary: Hopefully this patent will accelerate the development of diabetes treatments using stem cells.
No comments:
Post a Comment